Characterization of menopausal women affected by COVID-19

Authors

Keywords:

COVID-19, climacteric stage, intensity of climacteric syndrome, post-COVID endocrinopathies

Abstract

Introduction: coronavirus is a disease caused by the SARS-CoV-2 virus that affected the global population in 2019 (COVID-19 pandemic) and can exhibit unique characteristics in menopausal women.
Objective: to characterize menopausal women affected by COVID-19 at the "Idalberto Revuelta" Polyclinic in Sagua la Grande, Villa Clara.
Methods: a developmental study was conducted, through a descriptive cross-sectional study, in 57 women aged 40 to 59 years affected by COVID-19 from January 2021 to December 2022. Results: Women aged 55 to 59 years (40.35%), postmenopausal women (80.70%), and the subgroup at highest risk for COVID-19 (68.42%) predominated. Complications occurred in 7% of cases, and the most common post-COVID-19 endocrinopathies were subacute thyroiditis (8.77%) and type 2 diabetes mellitus (5.26%).
Conclusions: menopausal women with early postmenopause and a higher risk of COVID-19 complications predominated, which increased as the severity of menopausal syndrome increased. Among the post-COVID-19 endocrinopathies, subacute thyroiditis and type 2 diabetes mellitus were prominent.

Downloads

Download data is not yet available.

Author Biographies

Belkys Consuegra Dreke, “Martyrs of April 9” Hospital, Sagua la Grande, Villa Clara, Cuba.

First-level specialist in MGI and Endocrinology. Instructor professor

Vivian de la Caridad Betancourt Rodríguez, Arnaldo Milián Castro Provincial Clinical and Surgical University Hospital, Santa Clara, Villa Clara, Cuba

Second-level specialist in endocrinology. Assistant professor and consultant.

Noira Durán Morera, Mariana Grajales Coello Maternal Hospital, Santa Clara, Villa Clara, Cuba

First-level specialist in MGI and Biostatistics. Assistant Professor

René Manuel Cruz González, Arnaldo Milián Castro Provincial Clinical and Surgical University Hospital, Santa Clara, Villa Clara, Cuba

1st-level specialist in Endocrinology. Instructor professor

References

1. Okpechi SC, Fong JT, Gill SS, Harman JC, Nguyen TH, Chukwurah QC, et al. Disparidad global por sexo de COVID-19: una revisión descriptiva de las hormonas sexuales y consideración del uso terapéutico potencial de la terapia de reemplazo hormonal en adultos mayores. Aging Dis [Internet]. 2021 [citado 12/11/2024]; 27(1): [aprox. 2p.].Disponible en: https://pmc-ncbi-nlm-nih-gov.translate.goog/articles/PMC7990361/?_x_tr_sl=en&_x_tr_tl=es&_x_tr_hl=es&_x_tr_pto=tc

https://doi.org/10.14336/AD.2020.1211

2. Adhikari SP, Meng S, Wu YJ, Mao YP, Ye RX, Wang QZ, et al. Epidemiology,causes, clinical manifestation and diagnosis, prevention and control of coronavirus disease (COVID-19) during the early outbreak period: a scoping review. Infect Dis Poverty [Internet]. 2020 [citado 12/11/2024]; 9(1): [aprox. 2p.].Disponible en: https://pubmed.ncbi.nlm.nih.gov/32183901/

https://doi.org/10.1186/s40249-020-00646-x

3. Afonso de León JA, Sánchez Barrera O, Rodríguez Curbelo M, García García D, Cañete Villafranca R. Biomodulina T: una nueva opción terapéutica contra la COVID-19. Rev Méd Electrón [Internet]. 2021[citado 12/11/2024]; 43(6): [aprox. 3p.]. Disponible en: http://www.revmedicaelectronica.sld.cu/index.php/rme/article/view/42/5322

4. Neyro JL, Cristóbal I. Influencia de la CoVID19 sobre los tratamientos hormonales en Ginecología. Gac Med Bilbao [Internet]. 2020 [citado 12/11/2024]; 117(2): [aprox. 2p.]. Disponible en: https://www.gacetamedicabilbao.eus/index.php/gacetamedicabilbao/article/view/795

5. Rodríguez Cahill C. Cinco retos psicológicos de la crisis del COVID-19. JONNPR [Internet]. 2020 [citado 12/11/2024]; 5(6): [aprox. 2p.]. Disponible en: http://scielo.isciii.es/scielo.php?script=sci_arttext&pid=S2529-850X2020000600583&lng=es.

https://dx.doi.org/10.19230/jonnpr.3662.

6. García A, Gil JD, Pimiento M, Viveros JA, González AM. El elemento sexo en el COVID-19: mecanismos diferenciales en la susceptibilidad, la severidad y la mortalidad de la enfermedad por SARS-CoV-2. Rev Colomb Endocrinol Diabet Metab [Internet]. 2022 [citado 12/11/2024]; 9(4):e759. Disponible en: https://revistaendocrino.org/index.php/rcedm/article/view/759

https://doi.org/10.53853/encr.9.4.759

7. Wang R, Pan M, Zhang X, Fan X, Han M, Zhao F, et al . Epidemiological and clinical features of 125 Hospitalized Patients withCOVID-19. China International Journal of Infectious Diseases [Internet]. [citado 12/11/2024]; Disponible en: https://pubmed.ncbi.nlm.nih.gov/32289565/

https://doi.org/10.1016/j.ijid.2020.03.070).

8. Tang D, Comish P, Kang R. The hallmarks of COVID-19 disease. PLoS Pathog [Internet]. 2020 [citado 12/11/2024]; 16(5):e1008536.Disponible en: https://pubmed.ncbi.nlm.nih.gov/32442210/

https://doi.org/10.1371/journal.ppat.1008536

9. Navarro Despaine D, Artiles Visbal L. COVID-19: ¿Necesidad de incluir lamenopausia en la evolución de la enfermedad? Anales de la ACC [Internet]. 2021 [citado 12/11/2024]; 11 (1): [aprox. 3p.] Disponible en: https://scielo.sld.cu/scielo.php?script=sci_arttext&pid=S2304-01062021000100020&lng=es&nrm=iso>

10. Scully EP, Haverfield J, Ursin RL, Tannenbaum C, Klein SL. Considerando cómo el sexo biológicoafecta las respuestas inmunitarias y los resultados de COVID-19. Nat Rev Immunol [Internet]. 2020 [citado 12/11/2024]; 20:[aprox. 3p.].Disponible en: https://www-nature-com.translate.goog/articles/s41577-020-0348-8?error=cookies_not_supported&code=84796b6c-350e-4a1d-aece-d965eceefaf9&_x_tr_sl=en&_x_tr_tl=es&_x_tr_hl=es&_x_tr_pto=tc

https://doi.org/10.1038/s41577-020-0348-8

11. Mishra N, Sharma R, Mishra P, Singh M, Seth S, Deori T, et al. COVID-19 and menstrual status: Is menopause an independent risk factor for SARS Cov-2? J Mid- life Health [Internet]. 2020 [citado 12/11/2024]; 11: [aprox. 3p.].Disponible en: https://pmc.ncbi.nlm.nih.gov/articles/PMC7978058/

https://doi.org/10.4103/jmh.JMH_288_20

12. Zhang Y. Vital Surveillances. Características epidemiológicas de un brote de enfermedades causadas por el nuevo coronavirus de 2019 (COVID-19) China, 2020. Epidemiología de la respuesta de emergencia por neumonía por el nuevo coronavirus. China CDC Weekly [Internet]. 2020 [citado 12/11/2024]; 2(8): [aprox. 4p.].Disponible en: https://weekly-chinacdc-cn.translate.goog/article/id/e53946e2-c6c4-41e9-9a9b-fea8db1a8f51?_x_tr_sl=en&_x_tr_tl=es&_x_tr_hl=es&_x_tr_pto=tc

https://doi.org/10.46234/ccdcw2020.032

13. Pérez López FR, Tajada M, Savirón Cornudella, R, Sánchez Prieto M, Chedraui P, Terán E. Coronavirus disease 2019 and gender related mortality in European countries: A meta analysis. Maturitas [Internet]. 2020 [citado 12/11/2024]; 141:[aprox. 3p.].Disponible en: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7309755/

https://doi.org/10.1016/j.maturitas.2020.06.017

14. Garg R, Agrawal P, Gautam A, Pursnani N, Agarwal M, Agarwal A, et al. Resultados de COVID‐ 19 en mujeres posmenopáusicas y perimenopáusicas: ¿Se atribuye a los Estrógenos las diferencias? J Midlife Health [Internet]. 2020 [citado 12/11/2024]; 11 (4):[aprox. 3p.].Disponible en: https://pubmed.ncbi.nlm.nih.gov/33767567/

https://doi.org/10.4103/jmh.jmh_287_20

15. Jin JM, Bai P, He W, Wu F, Liu XF, Han DM, et al. Gender Differences in Patients With COVID-19: Focus on Severity and Mortality. Front Public Health [Internet]. 2020 [citado 12/11/2024]; 8: [aprox. 2p.]. Disponible en: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7201103/

https://doi.org/10.3389/fpubh.2020.00152

16. Ding T, Zhang J, Wang T, Cui P, Chen Z, Jiang J, et al. A Multi hospital Study in Wuhan, China: Protective Effects of Non menopause and Female Hormones on SARS-CoV-2 infection. Med Rxiv [Internet]. 2020 [citado 12/11/2024]. Disponible en: https://www.medrxiv.org/content/10.1101/2020.03.26.20043943v1

https://doi.org/10.1101/2020.03.26.20043943

17. Trenti A, Tedesco S, Boscaro C, Trevisi L, Bolego C, Cignarella A. Estrogen, Angiogenesis, Immunity and Cell Metabolism: Solving the Puzzle. Int J Mol Sci [Internet]. 2018 [citado 12/11/2024]; 19(3):[aprox. 2p.]. Disponible en: https://pubmed.ncbi.nlm.nih.gov/29543707/

https://doi.org/10.3390/ijms19030859 PMID:29543707.

18. Liu D, Ding HL, Chen Y, Chen DH, Yang C, Yang LM, et al. Comparison of the clinical characteristics and mortalities of severe COVID-19 patients between pre- and post-menopause women and age-matched men. Aging (Albany NY) [Internet]. 2021 [citado 12/11/2024]; 13(18): [aprox. 3p.].Disponible en: https://pubmed.ncbi.nlm.nih.gov/34551393/

https://doi.org/10.18632/aging.203532

19. López M, Vanhauwaert P, Barriga P, Lavin P, Porcila A, Parra M. Manual para Manejo de la Mujer en Edad de Climaterio. 2ed Chile: Sociedad Chilena de Endocrinología Ginecológica [Internet]. Chile: Socheg; 2020 [citado 12/11/2024]. Disponible en: https://www.endogin.org/Manual-Climaterio-SOCHEG-2020.pdf

20. Rivas E, Hernández Gutiérrez C, Zerquera Trujillo G, Vicente Sánchez B, Muñoz Cocina J. Factores biológicos y sociales relacionados con la salud de la mujer durante el climaterio. Medisur [Internet]. 2011 [citado 12/11/2024]; 9(6):[aprox. 4p.]. Disponible en: https://medisur.sld.cu/index.php/medisur/article/view/1212

21. Colectivo de autores. II Consenso Cubano sobre Climaterio y Menopausia. La Habana: Editorial CIMEQ; 2007 [citado 12/11/2024].Disponible en: https://www.sld.cu/galerias/pdf/sitios/ginecobs/consenso2006 seccclimy menop.pdf

22. Wright E, Shaltout O, Zokvic MA, Shirreff L. Delivery of menopause care during a pandemic: an evaluation of patient satisfaction with telephone visits. Menopause [Internet]. 2021 [citado 12/11/2024]; 29(2): [aprox. 4p.].Disponible en: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8785511/

https://doi.org/10.1097/GME.0000000000001906

23. Costeira R, Lee KA, Murray B, Christiansen C, Castillo Fernandez J, Lochlainn MN, et al. Estrogen and COVID‑19 symptoms: associations in women from the COVID Symptom Study. Med Rxiv [Internet]. 2020 [citado 12/11/2024]; 16(9):e0257051. Disponible en: https://pubmed.ncbi.nlm.nih.gov/34506535/

https://doi.org/1 0.1101/2020.07.30.20164921.

24. Navarro Despaigne D, Duany Navarro A, Manzano Ovies B, Sarduy Nápoles M. Una mirada biosocial a las características clínicas de adultos cubanos infectados por el virus SARS CoV2. Revista Cubana de Obstetricia y Ginecología [Internet]. 2020 [citado 12/11/2024]; 46(3):e680. Disponible en: https://revginecobstetricia.sld.cu/index.php/gin/article/view/680/

25. Mangia C, Russo A, Civitelli S, Gianicolo EA. Sex/gender differences in COVID-19 lethality: what the data say, and do not say. Epidemiol Prev [Internet]. 2020 [citado 12/11/2024]; 44(5-6 Suppl 2): [aprox. 3p.].Disponible en: https://pubmed.ncbi.nlm.nih.gov/33412835/

https://doi.org/10.19191/EP20.5-6.S2.145PMID:33412835.

26. Cagnacci A, Xholli A. Change in Covid-19 infection and mortality rates in postmenopausal women. Menopause [Internet]. 2021 [citado 12/11/2024]; 28(5): [aprox. 4p.].Disponible en: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8078005/

https://doi.org/10.1097/GME.0000000000001731

27. Zafari Zangenel F, Sarmast Shoushtari. Estradiol and Covid-19: Doc 17-Estradiol Have an Inmune-Protective Function in women against coronavirus? J Family Reprod Health [Internet]. 2021 [citado 12/11/2024]; 15(3): [aprox. 5p.]. Disponible en: https://pmc.ncbi.nlm.nih.gov/articles/PMC8536825/

https://doi.org/10.18502/jfrh.v15i3.7132

28. Correa V, Cabello S, Nilo F, Cerda J. Tiroiditis subaguda asociada a COVID-19: Revisión narrativa. ARS med (Santiago) [Internet]. 2023 [citado 12/11/2024]; 48(2): [aprox. 3p.]. Disponible en: https://www.arsmedica.cl/index.php/MED/article/view/1930

http://dx.doi.org/10.11565/arsmed.v48i2.1930.

29. Ruiz Domínguez R, Patiño Constancio E. Tiroiditis subaguda asociada con covid 19: reporte de tres casos. Rev Méd La Paz [Internet]. 2022 [citado 12/11/2024]; 28(2): [aprox. 4p.]. Disponible en: https://www.scielo.org.bo/scielo.php?script=sci_arttext&pid=S1726-89582022000200057

30. Lima Martínez MM, Carrera Boada C, Madera Silva MD, Marín W, Contreras M. COVID-19 and diabetes: A bidirectional relationship. Clin Investig Arterioscler [Internet]. 2021 [citado 12/11/2024]; 33(3): [aprox. 2p.].Disponible en: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7598432/

https://doi.org/10.1016/j.arteri.2020.10.001

Downloads

Published

2025-07-03

How to Cite

1.
Consuegra Dreke B, Betancourt Rodríguez V de la C, Durán Morera N, Cruz González RM. Characterization of menopausal women affected by COVID-19. Acta Méd Centro [Internet]. 2025 Jul. 3 [cited 2025 Jul. 6];19(1):e2279. Available from: https://revactamedicacentro.sld.cu/index.php/amc/article/view/2279

Issue

Vol. 19 (2025): PUBLICACIÓN CONTINUA

Section

Original Articles

License

Copyright (c) 2025 Belkys Consuegra Dreke, Vivian de la Caridad Betancourt Rodríguez, Noira Durán Morera, René Manuel Cruz González

Creative Commons License

This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.

Authors who have publications with this journal agree to the following terms:

  1. Authors will retain their copyright and assign to the journal the right of first publication of their work, which will simultaneously be subject to a Creative Commons License / Attribution-Noncommercial 4.0 International (CC BY-NC 4.0) that allows third parties to share the work as long as its author and first publication in this journal are indicated.
  2. Authors may adopt other non-exclusive license agreements for distribution of the published version of the work (e.g., depositing it in an institutional repository or publishing it in a monographic volume) as long as the initial publication in this journal is indicated.
  3. Authors are allowed and encouraged to disseminate their work through the Internet (e.g., in institutional telematic archives or on their web page) before and during the submission process, which can produce interesting exchanges and increase citations of the published work. (See The effect of open access).